TRIM32 is an E3 ubiquitin ligase for dysbindin

Human Molecular Genetics

Volumn 18, Issue 13, 2009, Pages 2344-2358

  Locke, Matthew ^a,b   Tinsley, Caroline L ^a   Benson, Matthew A ^b,c   Blake, Derek J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSBINDIN; SMALL INTERFERING RNA; TRIPARTITE MOTIF PROTEIN 32; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; TWO HYBRID SYSTEM; UBIQUITINATION; WILD TYPE;

ANIMALS; CARRIER PROTEINS; CELL LINE; HUMANS; MICE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; PROTEIN BINDING; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 67249131486     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp167     Document Type: Article

References (47)

1. Hershko, A. and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem., 67, 425-479.
2. Pickart, C.M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem., 70, 503-533.
3. Ravid, T. and Hochstrasser, M. (2008) Diversity of degradation signals in the ubiquitin-proteasome system. Nat. Rev., 9, 679-690.
4. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S. et al. (2001) The tripartite motif family identifies cell compartments. EMBO J., 20, 2140-2151.
5. Nisole, S., Stoye, J.P. and Saib, A. (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3, 799-808.
6. Takahashi, M., Inaguma, Y., Hiai, H. and Hirose, F. (1988) Developmentally regulated expression of a human 'finger'-containing gene encoded by the 5′ half of the ret transforming gene. Mol. Cell Biol., 8, 1853-1856.
7. Salomoni, P. and Pandolfi, P.P. (2002) The role of PML in tumor suppression. Cell, 108, 165-170.
8. Le Douarin, B., Zechel, C., Garnier, J.M., Lutz, Y., Tora, L., Pierrat, P., Heery, D., Gronemeyer, H., Chambon, P. and Losson, R. (1995) The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J., 14, 2020-2033.
9. Frosk, P., Weiler, T., Nylen, E., Sudha, T., Greenberg, C.R., Morgan, K., Fujiwara, T.M. and Wrogemann, K. (2002) Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am. J. Hum. Genet., 70, 663-672.
10. Quaderi, N.A., Schweiger, S., Gaudenz, K., Franco, B., Rugarli, E.I., Berger, W., Feldman, G.J., Volta, M., Andolfi, G., Gilgenkrantz, S. et al. (1997) Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat. Genet. 17, 285-291.
11. Avela, K., Lipsanen-Nyman, M., Idanheimo, N., Seemanova, E., Rosengren, S., Makela, T.P., Perheentupa, J., Chapelle, A.D. and Lehesjoki, A.E. (2000) Gene encoding a new RING-B-box-coiled-coil protein is mutated in mulibrey nanism. Nat. Genet., 25, 298-301.
12. (1997) A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat. Genet., 17, 25-31.
13. Jerusalem, F., Engel, A.G. and Gomez, M.R. (1973) Sarcotubular myopathy. A newly recognized, benign, congenital, familial muscle disease. Neurology, 23, 897-906.
14. Muller-Felber, W., Schlotter, B., Topfer, M., Ketelsen, U.P., Muller-Hocker, J. and Pongratz, D. (1999) Phenotypic variability in two brothers with sarcotubular myopathy. J. Neurol., 246, 408-411.
15. Schoser, B.G., Frosk, P., Engel, A.G., Klutzny, U., Lochmuller, H. and Wrogemann, K. (2005) Commonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H. Ann. Neurol., 57, 591-595.
16. Slack, F.J. and Ruvkun, G. (1998) A novel repeat domain that is often associated with RING finger and B-box motifs. Trends Biochem. Sci. 23, 474-475.
17. Edwards, T.A., Wilkinson, B.D., Wharton, R.P. and Aggarwal, A.K. (2003) Model of the brain tumor-Pumilio translation repressor complex. Genes Dev., 17, 2508-2513.
18. Gentry, M.S., Worby, C.A. and Dixon, J.E. (2005) Insights into Lafora disease: Malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc. Natl Acad. Sci. USA, 102, 8501-8506.
19. Saccone, V., Palmieri, M., Passamano, L., Piluso, G., Meroni, G., Politano, L. and Nigro, V. (2008) Mutations that impair interaction properties of TRIM32 associated with limb-girdle muscular dystrophy 2H. Hum. Mutat., 29, 240-247.
20. Kudryashova, E., Wu, J., Havton, L.A. and Spencer, M.J. (2009) Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic component. Hum. Mol. Genet., 18, 1353-1367.
21. Chiang, A.P., Beck, J.S., Yen, H.J., Tayeh, M.K., Scheetz, T.E., Swiderski, R.E., Nishimura, D.Y., Braun, T.A., Kim, K.Y., Huang, J. et al. (2006) Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc. Natl Acad. Sci. USA, 103, 6287-6292.
22. Blacque, O.E. and Leroux, M.R. (2006) Bardet-Biedl syndrome: An emerging pathomechanism of intracellular transport. Cell. Mol. Life Sci., 63, 2145-2161.
23. Moore, S.J., Green, J.S., Fan, Y., Bhogal, A.K., Dicks, E., Fernandez, B.A., Stefanelli, M., Murphy, C., Cramer, B.C., Dean, J.C. et al. (2005) Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: A 22-year prospective, population-based, cohort study. Am. J. Med. Genet. A, 132, 352-360.
24. Barnett, S., Reilly, S., Carr, L., Ojo, I., Beales, P.L. and Charman, T. (2002) Behavioural phenotype of Bardet-Biedl syndrome. J. Med. Genet. 39, e76.
25. Nachury, M.V., Loktev, A.V., Zhang, Q., Westlake, C.J., Peranen, J., Merdes, A., Slusarski, D.C., Scheller, R.H., Bazan, J.F., Sheffield, V.C. et al. (2007) A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell, 129, 1201-1213.
26. Yen, H.J., Tayeh, M.K., Mullins, R.F., Stone, E.M., Sheffield, V.C. and Slusarski, D.C. (2006) Bardet-Biedl syndrome genes are important in retrograde intracellular trafficking and Kupffer's vesicle cilia function. Hum. Mol. Genet., 15, 667-677.
27. Kudryashova, E., Kudryashov, D., Kramerova, I. and Spencer, M.J. (2005) Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. J. Mol. Biol., 354, 413-424.
28. Horn, E.J., Albor, A., Liu, Y., El-Hizawi, S., Vanderbeek, G.E., Babcock, M., Bowden, G.T., Hennings, H., Lozano, G., Weinberg, W.C. et al. (2004) RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis 25, 157-167.
29. Albor, A., El-Hizawi, S., Horn, E.J., Laederich, M., Frosk, P., Wrogemann, K. and Kulesz-Martin, M. (2006) The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in LGMD2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkB. J. Biol. Chem., 281, 25850-25866.
30. Benson, M.A., Sillitoe, R.V. and Blake, D.J. (2004) Schizophrenia genetics: Dysbindin under the microscope. Trends Neurosci., 27 516-519.
31. Benson, M.A., Newey, S.E., Martin-Rendon, E., Hawkes, R. and Blake, D.J. (2001) Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem., 276 24232-24241.
32. Holzfeind, P.J., Ambrose, H.J., Newey, S.E., Nawrotzki, R.A., Blake, D.J. and Davies, K.E. (1999) Tissue-selective expression of alpha-dystrobrevin is determined by multiple promoters. J. Biol. Chem., 274, 6250-6258.
33. Campbell, E.M., Dodding, M.P., Yap, M.W., Wu, X., Gallois-Montbrun, S., Malim, M.H., Stoye, J.P. and Hope, T.J. (2007) TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Mol. Biol. Cell, 18, 2102-2111.
34. Li, W., Zhang, Q., Oiso, N., Novak, E.K., Gautam, R., O'Brien, E.P., Tinsley, C.L., Blake, D.J., Spritz, R.A., Copeland, N.G. et al. (2003) Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat. Genet., 35, 84-89.
35. Starcevic, M. and Dell'Angelica, E.C. (2004) Identification of snapin and three novel proteins (BLOS1, BLOS2 and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). J. Biol. Chem., 279, 28393-28401.
36. Talbot, K., Eidem, W.L., Tinsley, C.L., Benson, M.A., Thompson, E.W., Smith, R.J., Hahn, C.G., Siegel, S.J., Trojanowski, J.Q., Gur, R.E. et al. (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest., 113, 1353-1363.
37. Li, W., Feng, Y., Hao, C., Guo, X., Cui, Y., He, M. and He, X. (2007) The BLOC interactomes form a network in endosomal transport. J. Genet. Genomics, 34, 669-682.
38. Salazar, G., Craige, B., Styers, M.L., Newell-Litwa, K.A., Doucette, M.M., Wainer, B.H., Falcon-Perez, J.M., Dell'Angelica, E.C., Peden, A.A., Werner, E. et al. (2006) BLOC-1 complex deficiency alters the targeting of adaptor protein complex-3 cargoes. Mol. Biol. Cell 17, 4014-4026.
39. Malicdan, M.C., Noguchi, S., Nonaka, I., Saftig, P. and Nishino, I. (2008) Lysosomal myopathies: An excessive build-up in autophagosomes is too much to handle. Neuromuscul. Disord., 18, 521-529.
40. Norton, N., Williams, H.J. and Owen, M.J. (2006) An update on the genetics of schizophrenia. Curr. Opin. Psychiatry, 19, 158-164.
41. Mukhopadhyay, D. and Riezman, H. (2007) Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science, 315, 201-205.
42. Joazeiro, C.A. and Weissman, A.M. (2000) RING finger proteins: Mediators of ubiquitin ligase activity. Cell, 102, 549-552.
43. Kamiya, A., Tan, P.L., Kubo, K., Engelhard, C., Ishizuka, K., Kubo, A., Tsukita, S., Pulver, A.E., Nakajima, K., Cascella, N.G. et al. (2008) Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: A candidate for psychiatric illnesses. Arch. Gen. Psychiatry, 65, 996-1006.
44. Datta, S.R., McQuillin, A., Rizig, M., Blaveri, E., Thirumalai, S., Kalsi, G., Lawrence, J., Bass, N.J., Puri, V., Choudhury, K. et al. (2008) A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia. Mol. Psychiatry. In press.
45. Burdick, K.E., Goldberg, T.E., Funke, B., Bates, J.A., Lencz, T., Kucherlapati, R. and Malhotra, A.K. (2007) DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr. Res., 89, 169-172.
46. Burdick, K.E., Lencz, T., Funke, B., Finn, C.T., Szeszko, P.R., Kane, J.M., Kucherlapati, R. and Malhotra, A.K. (2006) Genetic variation in DTNBP1 influences general cognitive ability. Hum. Mol. Genet., 15, 1563-1568.
47. Esapa, C.T., Waite, A., Locke, M., Benson, M.A., Kraus, M., McIlhinney, R.A., Sillitoe, R.V., Beesley, P.W. and Blake, D.J. (2007) SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: Modulation by ubiquitination and torsinA. Hum. Mol. Genet., 16, 327-342.